Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CrazyEights 

Resmed Inc. diskutieren

Resmed Inc.

WKN: 895878 / Symbol: RMD / Name: ResMed / Aktie / Ausrüstung & Versorgung / Large Cap /

216,80 €
-0,09 %

Einschätzung Buy
Rendite (%) 7,36 %
Kursziel 186,84
Veränderung
Endet am 26.04.25

ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $205.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 21,69 %
Kursziel 219,74
Veränderung
Endet am 24.06.25

ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $236.00 price target on the stock.
Ratings data for RMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 11,92 %
Kursziel 216,62
Veränderung
Endet am 02.08.25

ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $236.00 price target on the stock.
Ratings data for RMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,77 %
Kursziel 230,02
Veränderung
Endet am 02.08.25

ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $238.00 to $251.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat

Einschätzung Sell
Rendite (%) -0,64 %
Kursziel 161,78
Veränderung
Endet am 18.09.25

ResMed Inc. (NYSE: RMD) had its "underperform" rating re-affirmed by analysts at Wolfe Research. They now have a $180.00 price target on the stock.
Ratings data for RMD provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,82 %
Kursziel 251,24
Veränderung
Endet am 24.09.25

ResMed Inc. (NYSE: RMD) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $280.00 price target on the stock.
Ratings data for RMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,42 %
Kursziel 241,60
Veränderung
Endet am 26.09.25

ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Bank of America Co. from $240.00 to $270.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat

ResMed Inc. (NYSE: RMD) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat